SBIA
AMED

Sheaff Brock Investment Advisors’s Amedisys AMED Stock Holding History

Sheaff Brock Investment Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-20,974
Closed -$1.06M – 561
2016
Q2 		$1.06M Buy
+20,974
New +$1.06M 0.13% 157

Other funds holding AMED

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Sheaff Brock Investment Advisors's AMED Position: Q3 2016 in Review

Sheaff Brock Investment Advisors sold out of Amedisys (AMED) in Q3 2016, closing a stake of 20,974 shares — an estimated $1.06M sold.

Sheaff Brock Investment Advisors first reported a position in AMED in Q2 2016 and held it in 1 quarter. The position peaked at $1.06M in Q2 2016. 153 funds tracked by Wall St. Rank hold AMED as of Q3 2016.

  • Sheaff Brock Investment Advisors reported no remaining Amedisys position as of Q3 2016 after selling out during the quarter.
  • Sheaff Brock Investment Advisors sold 20,974 Amedisys shares in Q3 2016, an estimated $1.06M.
  • Sheaff Brock Investment Advisors first reported a position in Amedisys in Q2 2016 and held it in 1 quarter.
  • Sheaff Brock Investment Advisors's Amedisys position peaked at $1.06M in Q2 2016.
  • 153 funds tracked by Wall St. Rank held Amedisys as of Q3 2016.

Based on Sheaff Brock Investment Advisors's 13F filing for Q3 2016, filed 8 Nov 2016.